Resveratrol is a heavily studied anti-aging compound that’s increasingly popular due to it’s unique antioxidant, anti–inflammatory, and cell–protective benefits.
Researchers conducted a meta-analysis of 25 Resveratrol studies – and here we’ll provide you with the results and conclusions of those studies.
The Most Potent Form is Trans-Resveratrol
Patented Liposomal Technology
Resveratrol’s low solubility in water and susceptibility to being broken down by stomach acids and the digestive system, make it very difficult for the body to absorb and utilize. In clinical studies, less than 1% of oral Resveratrol makes it into the bloodstream. To significantly improve its efficacy and bioavailability, our Trans-Resveratrol utilizes Patented Liposomal Technology.
Studies Compared Changes in Health Risk-Factors
For the meta-analysis, researchers chose studies that had similar participants and health measurements.
They analyzed studies which measured mean changes in health risk-factors, including:
- cholesterol levels (total, LDL and HDL)
- body weight, body mass index (BMI) and waist circumference (WC)
- hemoglobin A1c (HbA1c)
- HOMA index, insulin, leptin, fasting glucose, fat percentage, and adiponectin level.
Results from 25 Human Studies on Resveratrol
The results showed that Resveratrol intake significantly lowered cholesterol and blood glucose levels (HbA1c, total cholesterol, LDL and HDL).